- Home
- REFI vs TCMD Comparison
REFI vs TCMD Comparison
Compare REFI & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFI
- TCMD
- Stock Information
- Founded
- REFI 2021
- TCMD 1995
- Country
- REFI United States
- TCMD United States
- Employees
- REFI N/A
- TCMD N/A
- Industry
- REFI Real Estate Investment Trusts
- TCMD Medical/Dental Instruments
- Sector
- REFI Real Estate
- TCMD Health Care
- Exchange
- REFI Nasdaq
- TCMD Nasdaq
- Market Cap
- REFI 306.1M
- TCMD 344.2M
- IPO Year
- REFI 2021
- TCMD 2016
- Fundamental
- Price
- REFI $15.39
- TCMD $14.50
- Analyst Decision
- REFI Buy
- TCMD
- Analyst Count
- REFI 2
- TCMD 0
- Target Price
- REFI $20.00
- TCMD N/A
- AVG Volume (30 Days)
- REFI 73.0K
- TCMD 134.5K
- Earning Date
- REFI 11-07-2024
- TCMD 11-04-2024
- Dividend Yield
- REFI 12.22%
- TCMD N/A
- EPS Growth
- REFI N/A
- TCMD 9789.88
- EPS
- REFI 1.97
- TCMD 1.36
- Revenue
- REFI $55,186,946.00
- TCMD $281,544,000.00
- Revenue This Year
- REFI N/A
- TCMD $9.66
- Revenue Next Year
- REFI $4.51
- TCMD $11.09
- P/E Ratio
- REFI $7.81
- TCMD $10.61
- Revenue Growth
- REFI 5.63
- TCMD 5.71
- 52 Week Low
- REFI $13.86
- TCMD $9.70
- 52 Week High
- REFI $17.65
- TCMD $16.95
- Technical
- Relative Strength Index (RSI)
- REFI 42.89
- TCMD 57.17
- Support Level
- REFI $15.37
- TCMD $14.18
- Resistance Level
- REFI $15.85
- TCMD $14.73
- Average True Range (ATR)
- REFI 0.13
- TCMD 0.37
- MACD
- REFI -0.00
- TCMD -0.01
- Stochastic Oscillator
- REFI 22.22
- TCMD 77.88
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.